The next-generation 4D-Nucleofector® Platform is the leading non-viral cell transfection method for a wide variety of cell types—even those traditionally hard to transfect
Simplified design reduces manufacturing time and offers improved functionality to help streamline antibody discovery, cell line development, cell therapy, and synthetic biology workflows
Combining the technologies of the two companies will enable the delivery of a revolutionary desktop protein and gene “bioprinter” with breakthrough speed and convenience